Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 7NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Plasmablastic Lymphoma 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Hodgkin Disease 1HIV Infections 1Glioma 1Glioblastoma 1Burkitt Lymphoma 1Astrocytoma 1

Interventions

Etoposide 5Rituximab 4Radiotherapy 4Methotrexate 4Cytarabine 4Cyclophosphamide 3Cisplatin 3Vincristine 2Specimen Handling 2Prednisone 2Peripheral Blood Stem Cell Transplantation 2Methylprednisolone 2Gemcitabine 2Fenretinide 2Doxorubicin 2Carmustine 2venetoclax 1tucatinib 1temsirolimus 1plerixafor 1pertuzumab 1palbociclib 1olaparib 1merphos 1liposomal amphotericin B 1ixabepilone 1ibrutinib 1ibritumomab tiuxetan 1fludarabine 1cobimetinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, Non-Hodgkin × carmustine, poliferprosan 20 drug combination × Clear all
NCT02797470 2026-05-18

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

AIDS Malignancy Consortium

Phase 1/2 Active not recruiting
11 enrolled 9 charts
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, T-Cell, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡